Gene copy numbers of erbB oncogenes in human pheochromocytoma

Oncology Reports

Volumn 9, Issue 6, 2002, Pages 1373-1378

  Sworczak, Krzysztof ^a   Zaczek, Anna ^b,c   Babinska, Anna ^a   Lisowska, Urszula ^b   Bielawski, Krzysztof P ^b   Falkiewicz, Bogdan ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

^c POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

Author keywords

Double differential polymerase chain reaction; erbB proto oncogenes; Gene amplification; Gene deletion; Pheochromocytoma

Indexed keywords

DNA; PARAFFIN;

ADOLESCENT; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; GENE AMPLIFICATION; GENE DOSAGE; GENETICS; HUMAN; MIDDLE AGED; PATHOLOGY; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; PROTO ONCOGENE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHILD; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB; HUMANS; MIDDLE AGED; PARAFFIN EMBEDDING; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION;

EID: 0036833698     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.6.1373     Document Type: Article

References (48)

1. Klingler HC, Klingler PJ, Martin JK, Smallridge RC, Smith SL and Hinder RA: Pheochromocytoma. Urology 57: 1025-1032, 2001. (Pubitemid 32455560)
2. Dannenberg H, Speel EJ, Zhao J, Saremaslani P, van der Harst E, Roth J, Heitz PU, Bonjer HJ, Dinjens WN, Mooi WJ, Komminoth P and de Krijger RR: Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. Am J Pathol 157: 353-359, 2000. (Pubitemid 30626902)
3. Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PLM, O'Riordan JLH, Toledo SPA, Smith DPA, Smith DP, Maher ER and Ponder BAJ: Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumor suppresor gene in sporadic and syndromic pheochromocytomas. J Med Genet 32: 934-937, 1995.
4. Eng C: RET proto-oncogene in the development of human cancer. J Clin Oncol 17: 380-393, 1999.
5. Lee NC and Norton JA: Multiple endocrine neoplasia type 2B-genetic basis and clinical expression. Surg Oncol 9: 111-118, 2000. (Pubitemid 32441863)
6. Wiench M, Wloch J, Wygoda Z, et al: Genetic diagnosis of Multiple Endocrine Neoplasia Type 2B. Pol J Endocrinol 51: 67-76, 2000.
7. Edstrom E, Frisk T, Farnebo F, Hoog A, Backdahl M and Larsson C: Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas. Int J Mol Med 6: 469-474, 2000.
8. Zbar B, Kishida T, Chen F, et al: Germline mutations in the von Hippel-Linadau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8: 348-357, 1996. (Pubitemid 26412151)
9. Spandidos DA: The effect of exogenous human ras and myc oncogene in morphological differentiation of the rat pheochromocyloma PC12 cells. Int J Dev Neurosci 7: 1-4, 1989.
10. Astuli D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F and Maher ER: Germline SDHD mutation in familial phaeochromocytoma. Lancet 357: 1181-1182, 2001. (Pubitemid 32378695)
11. Lombardi D, Palescandolo E, Giordano A and Paggi MG: Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death Differ 8: 470-476, 2001. (Pubitemid 32492767)
12. Keiser HR: Pheochromocytoma and related tumors. In: Endocrinology. 4th edition, Vol. 3. DeGroot LJ and Jameson JL (eds). W.B. Saunders Company, Philadelphia, pp1862-1883, 2001.
13. Babinska A, Sworczak K and Wajda Z: Malignant pheochromocytoma - a case report. Pol J Endocrinol 48: 179-186, 1997.
14. Gupta D, Shidham V, Holden J and Layfield L: Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas. Appl Immunohistochem Mol Morphol 8: 267-274, 2000.
15. John H, Ziegler WH, Hauri D and Jaeger P: Pheochromocytomas: can malignant potential be predicted? Urology 53: 679-683, 1999. (Pubitemid 29163029)
16. Herwig R, Glodny B and Pauli G: Prognoses of malignancy in cases of pheochromocytomas? Urology 56: 891-892, 2000.
17. Kubota Y, Nakada T, Sasagawa I, Yanai H and Itoh K: Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 176-179, 1998. (Pubitemid 28070495)
18. Kinoshita H, Ogawa O, Mishina M, Oka H, Okumura K, Yamabe H, Terachi T and Yoshida O: Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features. Urol Res 26: 29-32, 1998. (Pubitemid 28218179)
19. Maryniak RK, Szczaluba K, Ignatowska-Switalska M, Wocial B and Januszewicz W: Immunomorphological studies and cytometric DNA ploidy in diagnostics of pheochromocytoma. Pol J Pathol 51: 83-86, 2000. (Pubitemid 30461098)
20. Hynes NE: ErbB2 activation and signal transduction in normal and malignant mammary cells. J Mamm Gland Biol Neoplasia 2: 199-206, 1996.
21. Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137, 2001. (Pubitemid 33674041)
22. Olayioye MA, Neve RM, Lane HA and Hynes NE: The ErbB signaling network: receptor hcterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000. (Pubitemid 30428195)
23. Kim H and Muller WJ: The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res 253: 78-87, 1999.
24. Savelyeva L and Schwab M: Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett 167: 115-123, 2001. (Pubitemid 32706673)
25. Kamio T, Shigematsu K, Sou H, Kawai K and Tsuchiyama H: Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma. Hum Pathol 21: 277-282, 1990. (Pubitemid 20081227)
26. Roncalli M, Springall DR, Varndell IM, Gaitonde VV, Hamid Q, Ibrahim NB, Grimelius L, Wilander E, Polak JM and Coggi G: Oncoprotein immunorcactivity in human endocrine tumors. J Pathol 163: 117-127, 1991.
27. Castilla-Guerra L, Moreno AM, Fernandez-Moreno MC, Utrilla JC, Fernandez E and Galera-Davison H: Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas. Histopathology 31: 144-149, 1997. (Pubitemid 27357349)
28. De Krijger RR, van der Harst E, van der Ham F, Stijnen T, Dinjens WN, Koper JW, Bruining HA, Lamberts SW and Bosman FT: Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas. J Pathol 188: 51-55, 1999. (Pubitemid 29197314)
29. Evers MB, Rady PL, Tyring SK, Sanchez RL, Rajaraman S, Townsend CM and Thompson JC: Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery 112: 211-218, 1992.
30. Bielawski K, Zaczek A, Lisowska U, Dybikowska A, Kowalska A and Falkiewicz B: The suitability of DNA extracted from formalin-fixed, paraffin-embedded tissues for double differential polymerase chain reaction analysis. Int J Mol Med 8: 573-578, 2001.
31. Qiagen QIAamp Blood Kit and QIAamp Tissue Kit Handbook, 1997.
32. Sambrook J, Fritsch EF and Maniatis T: In: Molecular Cloning. A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
33. Brandt B, Vogt U, Harms F, Bosse U, Zänker KS and Assmann G: Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content. Gene 159: 29-34, 1995.
34. Brandt B, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G and Zänker KS: Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 159: 35-42, 1995.
35. Vogt U, Bielawski K, Schlotter CS, Bosse U, Falkiewicz B and Podhajska AP: Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human cancer. Gene 223: 375-380, 1998. (Pubitemid 29015946)
36. Wells A: EGF receptor. Int J Biochem Cell Biol 31: 637-643, 1999.
37. Goodman R and Herschman HR: Growth factor dependence of pheochromocytoma cells in chemically defined medium. J Neurosci Res f. 453-459, 1982. (Pubitemid 12032794)
38. Tsugawa M, Moriwaki K, Miyagawa J, Gomi M, Fujii H, lida S and Tarui S: Induction of differentiation of human phaeochromocytoma cells in culture by epidermal growth factor and insulin. Anticancer Res 7: 1161-1163, 1987.
39. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P and Ullrich A: EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4: 694-701, 1994.
40. Nakajima M, Kashiwagi K, Ohta J, Furukawa S, Hayashi K, Kawashima T and Hayashi Y: Nerve growth factor and epidermal growth factor rescue PC12 cells from programmed cell death induced by etoposide: distinct modes of protection against cell death by growth factors and a protein-synthesis inhibitor. Neurosci Lett 176: 161-164, 1994.
41. Malden LT, Novak U, Kaye AH and Burgess AW: Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711-2714, 1988.
42. Humphrey PA, Gangarosa LM, Wong AJ, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum OD, Friedman HS and Bigner DD: Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Biochem Biophys Res Commun 178: 1413-1420, 1991.
43. Schwechheimer K, Huang S and Cavenee WK: EGFR gene amplification - rearrangement in human glioblastomas. Int J Cancer 62: 145-148, 1995.
44. Gebhardt F, Burger H and Brandt B: Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations - a link between genetics and epigenetics. Histol Histopathol 15: 929-936, 2000. (Pubitemid 30488572)
45. Hung MC and Lau YK: Basic science of HER-2/neu: a review. Semin Oncol 26 (Suppl. 12): 51-59, 1999.
46. Carraway KL, Carothers Carraway CA and Carraway KL III: Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland. J Mamm Gland Biol Neoplasia 2: 187-198, 1997. (Pubitemid 127716447)
47. Siegel PM, Ryan ED, Cardiff RD and Muller WJ: Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 18: 2149-2164, 1999. (Pubitemid 29179172)
48. Junttila TT, Sundvall M, Maatta JA and Elenius K: Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10: 304-310, 2000. (Pubitemid 32422109)